RESEARCH PUBLICATIONS AND PRESENTATIONS

Peer-Reviewed Journal Articles

1. Gadelkarim I, Jones L, Qidwai U, Ratnarajan G. Clinical outcomes of PRESERFLO Microshunt procedure with mitomycin C alone versus with mitomycin C and bevacizumab. Ther Adv Ophthalmol. 2025;17. doi:10.1177/25158414241287421.

2. Memon MS, Mahmood T, Qidwai U, Ahsan S, Arslan M, Fahim MF. A comparative analysis of postoperative visual outcomes following cataract surgery with different brands of Monofocal Intraocular Lenses. Pak J Med Sci. 2024;40(1Part-I):195-199. doi:10.12669/pjms.40.1.8157. PMID: 38196465; PMCID: PMC10772437.

3. Mahmood T, Faheem MF, Ahsan S, Qidwai U. Ocular complications associated with diabetes and the risk of sustainable blindness: A real-world analysis. J Pak Med Assoc. 2023;73(7):1453–145.

4. Qidwai U. iMIGS: An innovative AI-based prediction system for selecting the best patient-specific glaucoma treatment. MethodsX. 2023;10(2):102209.

5. Jones L, Maes N, Qidwai U, Ratnarajan G. Impact of minimally invasive glaucoma surgery on the ocular surface and quality of life in patients with glaucoma. Ther Adv Ophthalmol. 2023;15. doi:10.1177/25158414231152765.

6. Qidwai U, Jones L, Ratnarajan G. A comparison of iStent combined with phacoemulsification and endocyclophotocoagulation (ICE2) with the PreserFlo MicroShunt and XEN-45 implants. Ther Adv Ophthalmol. 2022;14:25158414221125697. doi:10.1177/25158414221125697. PMID: 36246954; PMCID: PMC9554128.

7. Lin Z, Qidwai U, et al. A 5-year review of 1220 malignant periocular tumours in an English county. Eye (Lond). 2022. doi:10.1038/s41433-022-02113-3. PMID: 35614342.

8. Lin Z, Qidwai U. A multicentre review of the histology of 1012 periocular basal cell carcinomas. Eur J Ophthalmol. 2020.

9. Qidwai U. Blind deconvolution and classification of blurred retinal images. J Med Imaging Health Inform. 2011;1(3):307–316.

10. Qidwai U. Deconvolution techniques for enhancing and classifying retinal images. In: Chen CH, ed. Computer Vision in Medical Imaging. World Scientific Publishing; 2014:209–227. ISBN: 978-981-4460-93-4.

11. Dilshad Laghari, Rehman AU, Qidwai U. Intravitreal bevacizumab in different types of retinal vein occlusions. J Ayub Med Coll Abbottabad. 2015;27(3):677-9.

12. Kazi SB, Qidwai U. Isolated inferior oblique myectomy for hypertropia. J Ayub Med Coll Abbottabad. 2014;26(2).

13. Memon SB, Qidwai U. Surgical management of strabismus: Our experience. Ophthalmology Updates. 2014;2(2).

14. Memon SB, Qidwai U. Success rate of surgical correction methods in esotropias. Ophthalmology Updates. 2014;2(2).

15. Sadia B, Qidwai U. Surgical correction in constant and intermittent exotropias. J Coll Physicians Surg Pak. 2014.

16. Bhatti N, Qidwai U. Efficacy of sub-conjunctival bevacizumab in high-risk corneal transplantations. Pak J Ophthalmol. 2013;29(4).

17. Khan A, Qidwai U. Role of intravitreal bevacizumab before PPV in vitreous hemorrhage due to PDR. Pak J Ophthalmol. 2013;29(3).

18. Bhutto IA, Kazi GQ, Mahar PS, Qidwai A. Visual outcomes in Ab-externo scleral fixation IOL in pediatric aphakia. Pak J Med Sci. 2013;29(4):947-950.

19. Bhatti N, Qidwai U. Topical and subconjunctival bevacizumab in high-risk corneal transplant survival. J Pak Med Assoc. 2013;63(10):1256–9.

20. Hameed K, Khan A, Qidwai U. Ocular trauma in Balouchistan. Ophthalmology Updates. 2013;11(3).

21. Jaskani A, Qidwai U. Knowledge, attitude, and practice regarding diabetes and diabetic retinopathy in Karachi. Ophthalmology Updates. 2013;11(3).

22. Mahboob H, Rabbani A, Cheema AM, Qidwai U. Success rate of surgical correction of essential esotropia. Ophthalmology Updates. 2013.

23. Sadia B, Qidwai U. Management of amblyopia in children after cataract surgery. Ophthalmology Updates. 2013.

24. Bhatti N, Qidwai U. Topical bevacizumab in high-risk corneal transplant survival. Pak J Med Sci. 2013.

25. Memon WU, Jadoon Z, Qidwai U. Prevalence of diabetic retinopathy in patients aged 30+ attending diabetic clinics in Karachi. Pak J Ophthalmol. 2012;28(2).

26. Kazi GQ, Kazi U, Qidwai U. Intravitreal bevacizumab before cataract surgery in diabetic macular edema. Isra Med J. 2012;4(2):71–75.

27. Bhatti N, Qidwai U. Subconjunctival bevacizumab in corneal neovascularization. Pak J Ophthalmol. 2012;28(1):33–37.

28. Sadia B, Mahar PS, Qidwai U. Ocular trauma in children. Pak J Ophthalmol. 2011;27(4):208–213.

29. Nasir B, Fawad U, Munawar H, Qidwai U. Audit of cornea clinic patients at a tertiary hospital in Karachi. Pak J Ophthalmol. 2011;27(4):191–194.

30. Sadia B, Aziz UR, Israr B, Qidwai U. Presentation pattern of retinoblastoma. Pak J Ophthalmol. 2011;27(3).

31. Aimal K, Qamar R, Fayaz S, Qidwai U. Frequency and patterns of eye diseases in retina clinic. Pak J Ophthalmol. 2011;27(3).

32. Hassan M, Rehman A, Qidwai U. Visual outcomes in DME patients undergoing cataract surgery with/without bevacizumab. Asian J Ophthalmol. 2011;12(3):135–9.

33. Hassan M, Qidwai U. Visual outcome after intravitreal bevacizumab in CRVO-induced macular edema. Pak J Ophthalmol. 2011;27(1):84–88.

34. Hassan M, Kazi A, Qidwai U. Complications of silicone oil after PPV in RRD. Pak J Ophthalmol. 2011;27(1):68–72.

35. Rashid A, Mazhar H, Naimatullah S, Qidwai U. Visual outcomes and industrial ocular injury patterns. Pak J Ophthalmol. 2011;27(1):8–11.

36. Aimal K, Mahar PS, Azfar NH, Qidwai U. Ocular complications after intravitreal bevacizumab for CNV and RNV. Pak J Ophthalmol. 2010;26(4).

37. Hassan M, Alvi R, Qidwai U. Complications of phacoemulsification. Ophthalmology Update. 2009.